NEW YORK (360Dx) – The US Food and Drug Administration has issued a warning that ingesting high levels of biotin, also known as vitamin B7, can lead to incorrect lab test results.

The agency said it issued the warning because it is seeing an increase in the number of reported adverse effects related to the vitamin's impact on lab results, including one death of a patient taking high levels of biotin whose troponin tests results were falsely low.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mar
08
Sponsored by
Swift Biosciences

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.

Mar
13

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.

Apr
03

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.